Lum L, Chen C
Department of Cell Biology and Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Curr Med Chem. 2015;22(35):4091-103. doi: 10.2174/0929867322666150827094015.
Cell-to-cell signaling molecules such as the Wnt proteins that directly influence the expression of cell-type specific transcriptional programs are essential for tissue generation in metazoans. The mechanisms supporting cellular responses to these molecules represent potential points of intervention for directing cell fate outcomes in therapeutic contexts. Small molecules that modulate Wnt-mediated cellular responses have proven to be powerful probes for Wnt protein function in diverse biological settings including cancer, development, and regeneration. Whereas efforts to develop these chemicals as therapeutic agents have dominated conversation, the unprecedented modes-of-action associated with these molecules and their implications for drug development deserve greater examination. In this review, we will discuss how medicinal chemistry efforts focused on first in class small molecules targeting two Wnt pathway components--the polytopic Porcupine (Porcn) acyltransferase and the cytoplasmic Tankyrase (Tnks) poly-ADP-ribosylases--have contributed to our understanding of the druggable genome and expanded the armamentarium of chemicals that can be used to influence cell fate decision-making.
细胞间信号分子,如直接影响细胞类型特异性转录程序表达的Wnt蛋白,对后生动物的组织生成至关重要。支持细胞对这些分子作出反应的机制是指导治疗环境中细胞命运结果的潜在干预点。在包括癌症、发育和再生在内的多种生物学环境中,调节Wnt介导的细胞反应的小分子已被证明是研究Wnt蛋白功能的有力探针。尽管将这些化学物质开发成治疗药物的努力主导了相关讨论,但与这些分子相关的前所未有的作用模式及其对药物开发的影响值得更深入的研究。在这篇综述中,我们将讨论针对两种Wnt信号通路成分——多聚体刺鼠信号蛋白(Porcn)酰基转移酶和细胞质端锚聚合酶(Tnks)聚ADP核糖基转移酶——的一类小分子药物化学研究,是如何增进我们对可成药基因组了解,并扩充了可用于影响细胞命运决策的化学物质库的。